key: cord-0892878-mn0i9arh authors: Luo, Guangcheng; Zhang, Jun; Zhang, Shun; Hu, Bei; Hu, Lillian; Huang, Zhen title: High-quality RT-PCR with chemically modified RNA controls date: 2020-11-11 journal: Talanta DOI: 10.1016/j.talanta.2020.121850 sha: f98dac2df943d3cab7f348231da02d164bb9af40 doc_id: 892878 cord_uid: mn0i9arh In detecting infectious diseases, such as coronavirus 2019 (COVID-19), real-time reverse-transcription polymerase chain reaction (RT-PCR) is one of the most important technologies for RNA detection and disease diagnosis. To achieve high quality assurance, appropriate positive and negative controls are critical for disease detection using RT-PCR kits. In this study, we have found that commercial kits often adopt DNAs instead of RNAs as the positive controls, which can’t report the kit problems in reverse transcription, thereby increasing risk of the false negative results when testing patient samples. To face the challenge, we have proposed and developed the chemically modified RNAs, such as phosphoroselenaote and phosphorothioate RNAs (Se-RNA and S-RNA), as the controls. We have found that while demonstrating the high thermostability, biostability, chemostability and exclusivity (or specificity), both Se-RNA and S-RNA can be fine templates for reverse transcription, indicating their potentials as both positive and negative controls for RT-PCR kits. Novel coronavirus pneumonia is caused by severe acute respiratory syndrome coronavirus 2 (COVID-19 or SARS-CoV-2), which has infected over 18 million people and caused over seven hundred-thousand death [1, 2] . The early diagnosis of COVID-19 is critical for prevention and control of this worldwide pandemic [3] [4] [5] . Real-time reverse-transcription polymerase chain reaction (RT-PCR) is generally regarded as the most powerful strategy for COVID-19 diagnosis [6, 7] . However, recent studies have found that the current RT-PCR kits offer unsatisfactory results, due to high numbers of false negative results (approximately 40%) [7] [8] [9] [10] . False negative result is extremely dangerous and may cause many problems in COVID-19 prevention and epidemic control. Since this pathogen is highly infectious and deadly, persons with false negative results can easily infect other people around them, causing serious wide-spreading of the virus and badly impacting on the population. Instead of the detection kits themselves, false negative results are generally attributed to improper sample collection, transportation, storage and/or handling. However, a problematic RT-PCR kit, such as a kit with inappropriate controls and failed reverse transcription, can indeed cause false negativity as well. RT-PCR, which is one of the most widely-used RNA detection methods in foundmental research and disease diagnosis, is of two steps: reverse transcription ( Step 1) and quantitative real-time polymerase chain reaction (Step 2) [11] . Though it can detect RNA virtually as rapid and sensitive as DNA, RNA is vulnerable to RNase degradation, causing its inherent instability [12] . To make matters worse, RNases are nearly ubiquitous in surrounding environment and hard to eliminate, and they can rapidly degrade RNAs, including RNA samples and RNA controls. Though RNAs should be the positive controls in theory, in commercial RT-PCR kits, DNAs are normally used as the positive controls in practice, to avoid the RNA bio-degradation and face the chanlenge of preparation a large amount of inactivated or recombinant virus in a short period of time. The problem is that the positive control DNAs can't inspect and report a RT-PCR kit with failed reverse transcription step, thereby causing high risk of false negative results in disease diagnosis on the basis of RNA detection, J o u r n a l P r e -p r o o f such as the false negativity in the novel coronavirus pneumonia diagnosis [13] [14] [15] [16] . Thus, appropriate controls are essential for viral RNA detection with RT-PCR kits. In principle, the kits with any problems should be identified and reported by the positive and/or negative controls. In this study, however, we discovered that a problematic kit with failed reverse transcription escaped the internal inspections, causing false negative results in COVID-19 RNA detection. Further, we demonstrated that the current commercial RT-PCR kits generally adopt DNAs as positive controls, thereby offering false assurance on the problematic kit with failed reverse transcription and increasing risk of false negative. Our alarming finding indicates that the usage of DNA positive controls is not an ideal strategy for RT-PCR kits, and it may be a better choice to use RNA positive controls. Although canonical RNA is inherently unstable, the modified RNAs can be stable in nuclease resistance [17] and useful as potential therapeutics in disease treatment, such as hyperlipidemia, HCV, and others [18] . It is known that NTPαSe can be recognized by T7 RNA polymerase with high specificity and the transcribed phosphoroselenaote RNAs are nuclease-resistant [19] [20] [21] . Therefore, we have hypothesized that the modified RNAs by replacing the phosphate nonbridging oxygen with selenium or sulfur may be specifically and efficiently recorgnized by reverse transcriptase and work as RNA positive or negative controls of the RT-PCR kits. Following our hypothesis, we explored the potentials of phosphoroselenaote and phosphorothioate RNAs (Se-RNA and S-RNA) as both positive and negative controls. We have found that while demonstrating the high thermostability, biostability, chemostability and exclusivity (or specificity), both Se-RNA and S-RNA can be fine templates for reverse transcription, indicating their potentials as both positive and negative controls for RT-PCR kits. for 30 min, followed by inactivation at 80℃ for 5 min. We randomly chose six commercial RT-PCR kits (A-F; Figure 1 ) for COVID-19 virus detection in market, for this study. In order to investigate their positive controls, we digested them with RNase A or DNase I, followed by analysis with their RT-PCR kits, respectively. We found that all of them can be digested by DNase I, while resisting to RNase A digestion ( Figure 1A -F). This experiment result has indicated that these positive controls were DNAs. These experiments have been repeated for five times, and the results were consistent. can be enzymatically polymerized by T7 RNA polymerase ( Figure 3A ), into RNAs with enhanced stability [19] [20] [21] . We also found that Se-RNA and S-RNA can be efficiently recognized by reverse transcriptase, generating cDNAs ( Figure 3B ). Further, we demonstrated that both Se-RNA and S-RNA can be amplified and detected by RT-PCR ( Figure 3C ). Furthermore, we found that the detection limit of Se-RNA and S-RNA was similar to that of O-RNA (Table 2) , indicating the Se/S-RNA potential as the positive controls. In this study, we reported that RT-PCR kit with problems in reverse transcription replace DNAs as positive controls in commercial RT-PCR kits. Further, since using water as the negative control is not ideal for RT-PCR detection, especially for monitoring mis-detection. Non-specific RNA would be a better choice as negative control. Considering RNA bio-instability, RNA modification is necessary. Our experimental results have showed that the modified RNAs (Se-RNA and S-RNA) are more stable and exclusive (or specific), thereby reducing false negative results and working as preferable negative controls of RT-PCR. In conclusion, we have found that problematic commercial RT-PCR kit can cause false detection results and the commonly-used DNA positive controls can lead to false negativity, as they can't report the problems in reverse transcription. This World-Health-Organization Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Emerging coronaviruses: Genome structure, replication, and pathogenesis Consistent Detection of Novel Coronavirus in Saliva Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients Quantification of mRNA using real-time RT-PCR The many pathways of RNA degradation False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications, New Engl Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR Chemical Synthesis and Biological Application of Modified Oligonucleotides Therapeutic siRNA: state of the art Synthesis of Selenium-Triphosphates (dNTPαSe) for More Specific DNA Polymerization Efficient enzymatic synthesis of phosphoroselenoate RNA by using adenosine 5'-(alpha-P-seleno)triphosphate Efficient substrate cleavage catalyzed by hammerhead ribozymes derivatized with selenium for X-ray crystallography The authors have declared that no conflict of interest exists.